Pattern of medications prescribed for URI (upper respiratory tract infection) patients in medicine OPD of tertiary care teaching hospital, Ujjain

  • Dr Maulin Mehta Assistant Professor, Department of Pharmacology, R. D. Gardi Medical College, Ujjain, MP, India.
  • Dr Siddharth banode Assistant Professor, Department of Pharmacology, R. D. Gardi Medical College, Ujjain, MP, India.
  • Dr Ashutosh Chourishi Professor & Head, Department of Pharmacology, R. D. Gardi Medical College, Ujjain, MP, India.
Keywords: Polypharmacy, Antibiotic resistance, FDCs (Fixed Dose Combinations), Antihistamines


Objective: To obtain information on prescribing pattern of medications for URTI and comment on its effectiveness.

Materials and Method: This observational, non-interventional and prospective study was carried out on patients with URTI, >18 years of age and of either sex came to medicine OPD over a period of 3 months. All the relevant information related with prescribed medications were recorded in annexure. Data obtained from the study were entered in MS Excel 2007 and analyzed.

Result: Most common diagnosis was non specific URTI (50%), in total 96 prescriptions. Total 255 drugs were prescribed with average number of drugs per encounter were 2.65. Total percentages of encounters with antibiotic prescribed were 47.91%. Total numbers of FDCs prescribed were 10.38%, which include terbutaline+ambroxol (62.50%), amoxicillin+clavulanic acid (33.34%) and ampicillin+cloxacillin (4.16%). Total 47 antibiotics were prescribed, which were amoxicillin (28), amoxicillin+ clavulanic acid (9), azithromycin (9) and ampicillin+ cloxacillin (1). Out of total 255 drugs, antihistamines (27%, cetirizine) were prescribed for maximum number of time, followed by demulcents (20.24%, linctus syrup), antibiotics (19.02%), NSAIDS (18.21 %, paracetamol), bronchodilator (6.07%, terbutaline), mucolytic (6.07%, ambroxol) and antacids (3.23%, ranitidine).

Conclusion: Proper and effective prescribing pattern of medications, for any condition, is required to improve drug efficacy, decrease cost of therapy, adverse effects, drug-drug interaction and drug resistance.


Download data is not yet available.


1. Mazzaglia G, Greco S, Lando C, Cucinotta G, Caputi AP. Adult acute upper respiratory tract infections in Sicily: pattern of antibiotic drug prescription in primary
care. J Antimicrob Chemother. 1998 Feb;41(2):259-66.

2. Jain N, Lodha R, Kabra SK. Upper respiratory tract infections. Indian J Pediatr. 2001 Dec;68(12):1135-8.

3. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.
JAMA. 1997 Sep 17;278(11):901-4.

4. Campbell H. Acute respiratory infection: a global challenge. Arch Dis Child. 1995 Oct;73(4):281-3.

5. Roy V, Malhotra R, Tayal V, Bansal A, Gupta KS. Fixed-dose combinations for cough and common cold in India: an assessment of availability and rationality.
Fundam Clin Pharmacol. 2011 Apr;25(2):258-66. doi: 10.1111/j.1472-8206.2010.00840.x.

6. Mainous AG 3rd, Hueston WJ, Davis MP, Pearson WS. Trends in antimicrobial prescribing for bronchitis and upper respiratory infections among adults and children. Am J Public Health. 2003 Nov;93(11):1910-4.

7. Huchon GJ, Gialdroni-Grassi G, Leophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotics therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J. 1996;9:1590–5. [PubMed]

8. Irvine DA. The general practitioner and upper respiratory tract infection in childhood. Fam Pract. 1986 Jun;3(2):126-31.

9. Pichichero ME. Culture and antigen detection tests for streptococcal tonsillopharyngitis. Am Fam Physician. 1992 Jan;45(1):199-205.

10. Orr PH, Scherer K, Macdonald A, Moffatt ME. Randomized placebo-controlled trials of antibiotics for acute bronchitis: a critical review of the literature. J Fam
Pract. 1993 May;36(5):507-12.

11. Stone S, Gonzales R, Maselli J, Lowenstein SR. Antibiotics prescribing for patients with colds, upper respiratory infections, and bronchitis: A national study of
hospital – based emergency departments. Ann Emerg Med. 2000;36:320–7.

12. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001 Sep 15;33(6):757-
62. Epub 2001 Aug 21.

13. Martin RM. When to use a new drug. Aust Prescr 1998;21:67-68

14. Snow V, Mottur-Pilson C, Gonzales R; American College of Physicians-American Society of Internal Medicine; American Academy of Family Physicians; Centers for Disease Control; Infectious Diseases Society of America. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med. 2001 Mar 20;134(6):487-9.

15. Nandimath MK and Ahuja S. Drug prescribing pattern in upper respiratory tract infection in children aged 1–14 years. International Journal Of Pharma and Biosciences.2012;3(1):299-308

16. Tripathi KD. Beta-lactam antibiotics. Essentials of medical pharmacology. 7th edition, 2013; 51: 716-732.

17. Tripathi KD. Drugs for cough and bronchial asthma. Essentials of medical pharmacology. 7th edition, 2013; 16: 218-233.

18. Luks D, Anderson MR. Antihistamines and the common cold. A review and critique of the literature. J Gen Intern Med. 1996 Apr;11(4):240-4.

19. Pratter MR. Cough and the common cold: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1 Suppl):72S-74S.

20. Gwaltney JM, Jr, Park J, Paul RA, Edelman DA, O'Connor RR, Turner RB. Randomized controlled trial of clemastine fumarate for treatment of experimental
rhinovirus colds. Clin Infect Dis. 1996 Apr;22(4):656-62.
How to Cite
Dr Maulin Mehta, Dr Siddharth banode, Dr Ashutosh Chourishi. Pattern of medications prescribed for URI (upper respiratory tract infection) patients in medicine OPD of tertiary care teaching hospital, Ujjain. Biomed Rev: J Basic Appl Med Sci [Internet]. 2015Dec.31 [cited 2021Jun.14];2(4):82-6. Available from:
Original Article